We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Gene and Cell Therapy – News and Features

News

Creating Ideal Neural Cells for Clinical Use

New protocol differentiates human embryonic stem cells into committed neural precursor cells.
News

UCSF Team Closer to Creating Safe Embryonic-Like Stem Cells

Researchers have for the first time used microRNAs to help turn adult mouse cells back to their embryonic state.
News

ThermoGenesis Announces Abstracts to Be Presented at Upcoming Stem Cell Therapy Conference

The abstracts will cover the efficacy of the Company's BioArchive® System, MarrowXpress™ (MXP™) and Res-Q™ devices in the processing of stem cells.
News

Tiny “Lab-on-a-Chip” Can Detect Pollutants, Disease and Biological Weapons

For centuries, animals have been the first line of defense against toxins.
News

Virgin Health Bank QSTP Holds Inaugural Meeting

The newly formed partnership between Virgin Health Bank and Qatar Science & Technology Park held its inaugural board meeting in Doha.
News

Virgin Health Bank Launches Stem-Cell Bank in Qatar

The benefits of stem cell therapies will soon be realized for the people of Qatar as Virgin Health Bank establishes a partnership with Qatar Science & Technology Park.
News

Stemcells to Acquire Cell-Based Drug Discovery Platforms and Related Businesses of Stem Cell Sciences

StemCells acquires the operating subsidiaries and certain related assets of SCS for 2,650,000 shares of StemCells common stock.
News

ISSCR Calls for Adherence to Recent Guidelines

Tumors After Attempted Stem Cell Therapy Highlight Importance of Rigorous Standards Before Clinical Treatment
News

Cardio3 BioSciences Treats First Patient with C-Cure® Stem Cell Derived Therapy for Heart Failure

The randomized, multi-center study designed to evaluate the ability of ‘cardiopoietic’ cells to restore cardiac function.
News

Oxford BioMedica Receives Further Investment under Agreement Led by the Foundation Fighting Blindness

The investment will support the continuing development of StarGen gene therapy for treatment of juvenile degenerative retinal disease.
Advertisement